Revolution Medicines
Utility Patents

Last updated:

List of all Revolution Medicines patents 8 in total

Status Patent
Grant
Utility: Solid forms of {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2- -oxa-8- azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol, a SHP2 inhibitor External link
Filling date: 6 Sep 2025 Issue date: 11 Jan 2022
Grant
Utility: Bicyclic heteroaryl compounds and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 9 Nov 2021
Grant
Utility: Compounds that participate in cooperative binding and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 13 Jul 2021
Grant
Utility: Identifying new therapeutic agents External link
Filling date: 6 Sep 2025 Issue date: 27 Apr 2021
Grant
Utility: C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors External link
Filling date: 6 Sep 2025 Issue date: 20 Apr 2021
Grant
Utility: Methods and reagents for analyzing protein-protein interfaces External link
Filling date: 6 Sep 2025 Issue date: 16 Mar 2021
Grant
Utility: 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric SHP2 inhibitors External link
Filling date: 6 Sep 2025 Issue date: 17 Mar 2020
Grant
Utility: Compounds that participate in cooperative binding and uses thereof External link
Filling date: 6 Sep 2025 Issue date: 14 Jan 2020

Showing 1 to 8 of 8 patents.